Department of Vision Sciences, University of Alabama at Birmingham, Birmingham, Alabama 35294-4390, USA.
J Biol Chem. 2011 Apr 1;286(13):11579-92. doi: 10.1074/jbc.M110.148627. Epub 2011 Jan 18.
To elucidate the morphological and cellular changes due to introduction of a charge during development and the possible mechanism that underlies cataract development in humans as a consequence of an additional charge, we generated a transgenic mouse model mimicking deamidation of Asn at position 101. The mouse model expresses a human αA-crystallin gene in which Asn-101 was replaced with Asp, which is referred to as αAN101D-transgene and is considered to be "deamidated" in this study. Mice expressing αAN101D-transgene are referred to here CRYAA(N101D) mice. All of the lines showed the expression of αAN101D-transgene. Compared with the lenses of mice expressing wild-type (WT) αA-transgene (referred to as CRYAA(WT) mice), the lenses of CRYAA(N101D) mice showed (a) altered αA-crystallin membrane protein (aquaporin-0 (AQP0), a specific lens membrane protein) interaction, (b) extracellular spaces between outer cortical fiber cells, (c) attenuated denucleation during confocal microscopic examination, (d) disrupted normal fiber cell organization and structure during scanning electron microscopic examination, (e) distorted posterior suture lines by bright field microscopy, and (f) development of a mild anterior lens opacity in the superior cortical region during the optical coherence tomography scan analysis. Relative to lenses with WT αA-crystallin, the lenses containing the deamidated αA-crystallin also showed an aggregation of αA-crystallin and a higher level of water-insoluble proteins, suggesting that the morphological and cellular changes in these lenses are due to the N101D mutation. This study provides evidence for the first time that expression of deamidated αA-crystallin caused disruption of fiber cell structural integrity, protein aggregation, insolubilization, and mild cortical lens opacity.
为了阐明在发育过程中引入电荷所导致的形态和细胞变化,以及人类白内障形成的可能机制,我们构建了一种模拟天冬酰胺(Asn)第 101 位脱酰胺的转基因小鼠模型。该小鼠模型表达人αA-晶体蛋白基因,其中第 101 位的天冬酰胺(Asn)被天冬氨酸(Asp)取代,该突变被认为在本研究中发生了“脱酰胺化”。在本研究中,表达αAN101D-转基因的小鼠被称为 CRYAA(N101D)小鼠。所有品系均显示出αAN101D-转基因的表达。与表达野生型(WT)αA-转基因(称为 CRYAA(WT)小鼠)的晶状体相比,CRYAA(N101D)小鼠的晶状体表现出:(a)αA-晶体蛋白(水通道蛋白 0(AQP0),一种特定的晶状体膜蛋白)膜蛋白相互作用改变;(b)外皮质纤维细胞之间的细胞外空间增大;(c)共聚焦显微镜检查时去核减弱;(d)扫描电子显微镜检查时纤维细胞正常排列和结构破坏;(e)明场显微镜下后缝线扭曲;(f)光学相干断层扫描分析时,上皮质区出现轻度前晶状体混浊。与含有 WT αA-晶体蛋白的晶状体相比,含有脱酰胺化 αA-晶体蛋白的晶状体也显示出αA-晶体蛋白的聚集和更高水平的不溶性蛋白质,这表明这些晶状体的形态和细胞变化是由于 N101D 突变引起的。本研究首次提供证据表明,脱酰胺化αA-晶体蛋白的表达导致纤维细胞结构完整性破坏、蛋白质聚集、不溶性增加以及轻度皮质晶状体混浊。